目的 分析某院第二类口服精神药品的使用情况,为临床合理使用该类药品提供参考和依据。方法 采用回顾性研究方法对2018-2019年第二类口服精神药品的使用量、销售金额、用药频度(DDDs)、日均费用(DDC)、药品排序比(B/A)以及各主要科室分布进行统计和分析。结果 2018-2019年第二类精神药品的使用品种稳定,药品销售金额和构成比稳定增长。主要分布在脑系科、心血管科、消化科、精神科。艾司唑仑片、佐匹克隆胶囊、氯硝西泮片用量排名前三位,佐匹克隆胶囊、酒石酸唑吡坦片、艾司唑仑片销售金额及DDDs位于前三位。第二类精神药品的DDC基本保持稳定,盐酸曲马多胶囊DDC最大,艾司唑仑片DDC最小。佐匹克隆胶囊、劳拉西泮片、盐酸曲马多胶囊氯硝西泮片B/A接近于1,艾司唑仑片B/A最大,酒石酸唑吡坦片B/A最小。结论 该院第二类口服精神药品的使用基本合理。
Abstract
Objective To analyze the way in which second category oral psychotropic drugs are used in a particular hospital.Methods Using the retrospective study method,the amounts of second category oral psychotropic drugs used and sold,defined daily doses (DDDs),daily drug cost (DDC),drug sequences ratio (B/A) and distribution between the main departments between 2018 and 2019 were analyzed.Results The variety of second category psychotropic drugs used between 2018 and 2019 was stable,and the amount of sales and constituent ratio increased stably.These drugs were mainly used by patients with cerebral,cardiovascular or psychiatric diseases.The top three drugs used were estazolam tablets,zopiclone capsules and clonazepam tablets..Estazolam tablets,zolpidem tartrate tablets and zopiclone capsules were the top three in terms of amounts of sales and DDDs.The DDC of the second category psychotropic drugs was basically stable,with tramadol hydrochloride capsules as the highest and estazolam as the lowest.The B/A of zopiclone capsules,lorazepam tablets and tramadol hydrochloride capsules was close to 1,with the B/A of estazolam tablets as the highest and that of zolpidem tartrate tablets as the lowest.Conclusions On the whole,second category oral psychotropic drugs are used rationally in this hospital.
关键词
第二类精神药品 /
销售金额 /
用药频度 /
日均费用 /
合理用药
Key words
second category psychotropic drugs /
sales amount /
defined daily doses /
daily drug cost /
rational drug use
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 国家食品药品监督管理总局.麻醉药品和精神药品管理条例国务院令第442号[S].2005.
[2] 中国药典[S].二部.北京:中国医药科技出版社.2015:88-682.
[3] 陈新谦,金有豫,汤 光.新编药物学[M].18版.北京:人民卫生出版社,2018.
[4] 梁晓丽,杜燕京,吴 娜,等.2012-2016年北京医院第二类精神药品使用情况统计与分析[J].临床药物治疗杂志,2017,15(9):16-20.
[5] 沈德蕾,张 瑛,赵 超,等.社区门诊处方苯二氮类药物人群的横断面研究 [J].中华临床医师杂志,2013,7(7):2932-2935.
[6] 伏晶琼,于庆华,陆成华.唑吡坦联合帕罗西汀治疗抑郁失眠的临床研究[J].现代药物与临床,2016,31(8):1264-1267.
[7] 王小亚.酒石酸唑吡坦片对急性脑卒中后失眠的治疗分析[J].中国医药指南,2014,12(17):161-162.
[8] 黄永涛,覃 军,高旭滨,等.唑吡坦改善高原睡眠的效果及其作用机制探讨[J].中国临床研究,2015,28(5): 624-627.
[9] 黎 苏,祁英杰,项 婧,等.2013-2014年辽宁省肿瘤医院麻醉药品使用情况分析[J].现代药物与临床,2015,30(12):1538-1541.
[10] 牛雅娟,刘铁桥,赵 敏.苯二氮类药物在特殊人群中的使用[J].中国药物滥用防治杂志,2017,23(7):196-198.
基金
天津市科委自然科学基金(043609011)